DERMA UNDER EYE- hyaluronic acid, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 gel 
Pella Pharmaceuticals Co. Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Under Eye

Forms and Presentation

Gel: Tube of 15 g.

Active Ingredients

Hyaluronic Acid

Palmitoyl Tripeptide-1

Palmitoyl Tetrapeptide-7

Inactive Ingredients

Aqua, Glycerin, Cetearyl Ethylhexanoate, Benzyl Alcohol, Polysorbate 20, Sodium Hydroxide, Carbomer, Hydroxyethylcellulose, Potassium Sorbate, Steareth-20, N- Hydroxysuccinimide, Chrysin.

Purpose

Under eye gel for dark circles

Properties

Under eye gel reduces dark circles and fine lines around the eye, therefore moisturizes and brightens it.
Paraben free.

Indications

Gel for Dark circles under eye.

Precautions

Keep out of reach of children

Warnings

Contraindications

Hypersensitivity to any of the components.

Side effects

There are no known side effects.

Dosage and administration

After cleansing, apply the gel onto your finger and gently pat it around your eyes. Use it morning and evening on Dark Circles.

Storage conditions

Store at a temperature below 30 °C.

Primary Package

Primary Package

Secondary Package

Secondary Package

DERMA UNDER EYE 
hyaluronic acid, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82160-443
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M) (PALMITOYL TRIPEPTIDE-1 - UNII:RV743D216M) PALMITOYL TRIPEPTIDE-10.0003 mg  in 15 g
HYALURONIC ACID (UNII: S270N0TRQY) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONIC ACID0.15 mg  in 15 g
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R) (PALMITOYL TETRAPEPTIDE-7 - UNII:Q41S464P1R) PALMITOYL TETRAPEPTIDE-70.00015 mg  in 15 g
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
STEARETH-20 (UNII: L0Q8IK9E08)  
N-HYDROXYSUCCINIMIDE (UNII: MJE3791M4T)  
CHRYSIN (UNII: 3CN01F5ZJ5)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
CARBOMER 940 (UNII: 4Q93RCW27E)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
WATER (UNII: 059QF0KO0R)  
CETEARYL ETHYLHEXANOATE (UNII: 9M64UO4C25)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82160-443-011 in 1 CARTON12/24/2014
115 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/24/2014
Labeler - Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 11/2021
Document Id: d1e98e79-2ab2-4d15-e053-2995a90a63b6
Set id: d1e98e79-2ab1-4d15-e053-2995a90a63b6
Version: 443
Effective Time: 20211129
 
Pella Pharmaceuticals Co. Ltd